OBJECTIVES: The aim of this study was to determine cardio-respiratory changes after endothoracic sympathetic denervation and their correlation with the extent of denervation.
INTRODUCTION
Essential palmar hyperidrosis (EPH) is characterized by excessive sweating of the palms of the hands and has serious consequences for the social and professional life of an affected person. The exact cause is unknown, although overactivity of the sympathetic fibres that pass through the thoracic sympathetic ganglia T2 and T3 has been noted. Conventional medical therapies with anti-colinergic drugs or topical aluminium chloride hexahydrate are inconvenient, unpleasant and only temporarily effective. The traditional sympathectomy procedure consists of excision of the sympathetic chain ganglion ('sympathectomy') at multiple levels generally ranging from the T2 to T3 ganglia [1] in palmar forms, with the additional excision of the T4 ganglion in axillary forms [2] . The procedure is safe, and compensatory hyperhidrosis is the side effect most frequently reported. Although difficult to prove, it appears that compensatory sweating was more severe with the removal of more ganglions [3] . On the basis of such findings, some authors have recently performed limited sympathectomy [4, 5] . Rarely, sympathectomy may cause changes in cardio-pulmonary function. Although sympathetic innervation is sparse and outnumbered with respect to parasympathic innervation in the air way, recently, few papers showed after sympathectomy a bronchial hyper-responsiveness with a reduction in small airways [6] [7] [8] [9] [10] , and a lower heart rate (HR) at rest and during maximal exercise [11] [12] [13] . These results are probably due to loss of the capacity of the sympathetic nervous system (SNS) to respond. Although a more selective and limited sympathetic resection may minimize such phenomenon, it remains unclear and not well investigated. Thus, to answer this question in a prospective randomized manner, we studied the cardio-pulmonary effects using two different strategies for endoscopic thoracic sympathectomy (ETS), the excision of T2 and T3 ganglia (sympathectomy) against a more limited procedure as the separation of the sympathetic chain between the T2 and T3 ganglion ('sympathicotomy'). The goal is to determine whether cardio-respiratory changes occur after sympathetic denervation and whether these changes are correlated with the extent and type of denervation.
MATERIALS AND METHODS

Study design
This prospective, single centre study included a consecutive series of patients undergoing bilateral ETS for EPH performed at the Thoracic Surgery Unit of the Second University of Naples from January 2007 to May 2010. Pre-randomization procedures consisted of a careful evaluation of inclusion and exclusion criteria. Inclusion criteria were as follows: age >18 and <50; no contraindications for anaesthetic procedure with double-lumen endotracheal intubation; severe palmar hyperhidrosis. Exclusion criteria included age <18 and >50; pleural, lung, cardiac disease and/or taking medications for cardio-pulmonary effects; secondary hyperhidrosis including hyperthyroidism, acute and chronic infections, malignancy and immunologic disorder; mild or moderate palmar hyperhidrosis. Randomization was performed following a computer-generated list. Patients were allocated to either T2-T3 sympathectomy (CG) or T2-T3 sympathicotomy (SG) using sequentially numbered sealed envelopes containing information disclosing the type of treatment to be applied. Patients underwent respiratory and cardiovascular exercise tests before, at 2 weeks and again at 6 months after the procedure; and the results were then evaluated. The study protocol was approved by the Hospital Ethics Committee of the Second University of Naples and written informed consent was obtained from all the patients before entering the study.
Study population
A total of 48 patients with EPH were evaluated. The patients underwent surgery after they had been previously deemed intolerant or had failed medical therapy for their symptoms. They received a detailed consultation to evaluate personal, professional and social handicaps related to palmar hyperhidrosis. A preoperative X-ray was performed to exclude lung or pleural disorders. Three patients were excluded because they did not meet the inclusion criteria: one patient was asthmatic; one patient presented vagal symptoms; and another patient was affected by hypertension. Thus, 45 patients were enrolled in the present study. They were randomized into two groups: CG (23 patients) and SG (22 patients).
Pulmonary functional tests
Spirometric examinations were performed before and at 2 weeks and 6 months after the procedure. Recorded parameters were forced expiratory volume in 1 s (FEV 1), forced vital capacity (FVC), forced expiratory flow between 25 and 75% of vital capacity (FEF 25-75% ), residual volume (RV), total lung capacity (TLC) and airway resistance (Raw). All parameters except Raw are expressed in percentage of the predicted values. Raw units are expressed as kPa/l/s.
Cardiovascular exercise test
The cardiovascular exercise test was performed with a cycle ergometer using a maximal, symptom-limited incremental exercise testing protocol consisting of 1 min stages with increments of power of 15-20 watts (woman) or 25-30 watts (men) per minute until either maximal tolerance is reached or the appearance of signs and symptoms requires interruptions of the exercise. For each minute, the watts were measured and totalled at the end of the test. Twelve-lead ECG and transcutaneous oxygen saturation data were collected continuously and stored on-line. For each minute, systolic and diastolic blood pressure (mmHg) and HR (bpm) were measured, and recorded at rest and at maximal effort; other parameters analysed were the oxygen uptake (VO 2 ) and carbon dioxide output (VCO 2 ).
Other data
During the follow-up, patients were asked to rate the operative outcome of their procedure as 1 for no change, 2 for satisfactory and 3 to denote a significant improvement and its impact on their quality of life [14] . Compensatory hyperhidrosis was graded as follows: G1 = absence; G2 = minor; G3 = embarrassing and G4 = disabling. Disabling was defined as sweating necessitating a change of underwear more than twice a day.
Operative procedure
Selective bilateral sympathectomy was performed in a one-stage procedure. All surgical procedures were performed by the same surgeon. General anaesthesia using a single-lung ventilation technique was applied in all the patients. A slight degree of cranial elevation and the lateral thoracotomy position helps the lungs to drop away from the operating site exposing the sympathetic chain. Immediately after the induction of anaesthesia, the first port was placed in the third or fourth intercostal space below and anterior to the inferior angle of the scapula. A 10-mm zero-degree telescope was passed through this port. A further port of 5 mm was placed for instrumentation at the level of the space between the third and fourth ribs in the anterior axillary line. The sympathetic chain was identified at the level of the crossing of the fourth, third and second costal heads. The parietal pleura was opened. In the CG, the ablation of T2 and T3 sympathetic ganglia was performed through electrocautery. In the SG, sympathectomy consisted of only a section of the chain by electrocoagulation between the T2 and T3 ganglia. All procedures were completed by insertion of a 16F chest tube through a trocar, and the lung was re-inflated under visual control. The chest tube was aspirated while the anaesthesiologist ventilated the patient manually, exerting continuous positive pressure for a few seconds, to prevent pneumothorax before the drain was subsequently removed.
Statistical analysis
Results are reported as means and standard deviations for continuous variables and as percentages for categorical variables. Intra-and intergroup differences were assessed by paired t-test. P < 0.05 was considered statistically significant. MedCalc ® statistical software was used for statistical analysis.
RESULTS
Two patients in the CG and one patient in the SG did not complete the study. Thus, each group counted 21 patients. A study flow diagram according to CONSORT guidelines [15] is shown in Fig. 1 . The characteristics of the two study groups are summarized in Table 1 . During the postoperative period, only one patient of the SG had pneumothorax which required placement of a Heimlich valve. This patient was discharged on the 2nd postoperative day without sequel. The remaining patients were discharged without complications 24 h after the procedure.
Pulmonary functional tests
The results of the SG and of the CG are summarized in Tables 2  and 3 , respectively.
In the SG, FEV 1 and FVC were reduced only at 2 weeks after the procedure, but returned to baseline values after 6 months. No significant alterations of the other spirometric values were registered ( Fig. 2A) . In the CG, FEV 1, FVC and FEF 25-75% were significantly reduced, while Raw significantly increased during the entire follow-up; RV and TLC did not show relevant alterations after operation (Fig. 2B ). Between the two groups, significant differences were found regarding FEV1 (P < 0.05; Fig. 3A ), FVC (P < 0.05; Fig. 3B ), FEF 25-75% (P < 0.05; Fig. 3C ) only at 6 months after the procedure, whereas Raw increased in the CG when compared with the SG at 2 weeks (P < 0.05) and 6 months after (P < 0.05). All respiratory changes remain sub-clinical, and no patients complained of respiratory symptoms such as dyspnoea. 
Cardiovascular exercise test
The results of the SG and CG groups are summarized in Tables 4  and 5 , respectively. In the SG, compared with the baseline value, no significant changes were observed regarding cardiovascular, ventilator, metabolic and ECG parameters; physical working capacity remained unchanged before and after the operation.
In the CG, HRs at rest and at peak exercise were significantly reduced during the entire follow-up when compared with preoperative values. No significant changes were observed regarding the other variables.
Comparing the values of SG and CG, significant differences were found regarding only the HRs at rest and at peak exercise at 2 weeks (P < 0.05) and 6 months (P < 0.05) after operation.
Despite such differences in HR, all patients completed the test, and no relevant difference was observed in working capacity before and after operation.
Other data
In all patients of both groups, the disappearance of hyperhidrosis after sympathetic denervation was confirmed. All patients expressed high satisfaction for the results obtained with significant improvement in their quality of life. In the follow-up visit 6 months after surgery, compensatory hyperhidrosis (grade 1) was present in only one patient of the CG. However, the symptoms were well tolerated and no further treatment was sought for him.
DISCUSSION
EH is a pathological condition of excessive sweating at the palms of the hands, characterized by an increased sympathetic activity of the upper dorsal sympathetic ganglia to eccrine sweat glands.
ETS is now recognized as effective treatment for arresting severe hand sweating, and the development of an easy and safe video-assisted procedure has allowed for a rapid spread of its application. A variety of different surgical procedures have been used over time with varying results. At present, there is no consensus for the surgical procedure regarding the type (i.e. sympathectomy or sympathicotomy) and the extent of denervation (i.e. single-or multiple-level denervation). Generally, most authors performed the ablation with electrocautery or laser, of the T2 and T3 sympathetic ganglia in palmar forms, with the additional excision of the T4 ganglion in axillary forms [1, 2] . The term 'sympathectomy' historically referred to extirpation or destruction of the sympathetic ganglia and chain, and the term 'sympathicotomy' meant severing the sympathetic chain. The modern day usage by the lay public has extended the term thoracic sympathectomy to include the latter operative technique 2.4 ± 0.4 2.5 ± 0.4 2.5 ± 0.4 O 2 pulse at peak (ml/beat) 9.6 ± 0.7 9.7 ± 0.9 10 ± 0.8
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as well because, from a functional perspective, the two technical approaches produce the same desired effects, that is, the term 'sympathectomy' is often used synonymously with 'sympathicotomy' [4] . However, Atkinson et al. [5] showed that sympathicotomy appears to lower the severity of postoperative compensatory hyperhidrosis when compared with sympathectomy without having higher risk of hyperhidrosis recurrence. Since post-ganglionic sympathetic fibres originating from cell bodies residing in the cervico-thoracic and upper thoracic ganglia participate in innervation of the central thoracic organs as the heart and lung, the ETS procedure theoretically would have effect on cardio-respiratory function. Few studies have shown a decrease in the HR and significant effects on pulmonary function variables after ETS [6] [7] [8] [9] [10] [11] [12] [13] ; but if they are correlated with the type of denervation, it remains unclear.
First, in the SG, no bronchomotor tone changes were observed. A significant reduction in FVC and FEV1 was registered only in the early postoperative follow-up and disappeared after. Thus, it is reasonable that these changes can be ascribed to a 'volume restrictive' effect of the thoracoscopy rather than to a sympathetic denervation. Conversely, in the CG, the reduction in FEV 1 and FVC was significantly reduced when compared with the preoperative values at the time of the first and of the second re-evaluation. Yet, the bronchomotor changes in the CG was confirmed by the significant decrease in FEF 25-75% and Raw observed during the entire follow-up; because they are sensitive tests of expiratory flow through small airways, their decrease is one of the earliest indices of the commencement of obstructive airway disease [16] . The first study on pulmonary function after thoracic sympathectomy were published by Molho et al. [7] who used supraclavicular or transaxillar approaches for sympathectomy in 24 patients. Compared with our data, they found a more dramatic pulmonary constriction; at 3 weeks after operation, both FVC and FEV 1 decreased by 29 and 30%, respectively. Because these alterations tended to normalize after 6 months, they can be ascribed, at least in part, to thoracotomy, which causes a restrictive pattern in pulmonary function tests. Subsequent studies investigated the respiratory changes after sympathetic denervation performed through video-endoscopic procedure. Tseng and Tseng [8] showed a significant reduction in FEV 1 (−6.1%), FVC (−2.3%) and FEF 75% (−8%) 1 month after the procedure. However, the postsurgical period allowed was too short, and this left the possibility that the changes were directly related to the surgical trauma as observed at the first measurement in the SG. Noppen and Vincken [9] observed a significant reduction in FEV 1 (−2.8%), FVC (−1.9%) and FEF 75% (−6.5%) 3 months after the procedure as observed in the CG of our study. González et al. [2, 6] in two different studies evaluated 25 and 32 patients at 12 months and at 24 months after ETS, respectively; they found that FEV1 and FEF 25-75% remained significantly decrease, whereas the FVC returned to the baseline value. The findings that FVC returned to preoperative range, together with a persistent reduction in FEV 1 and FEF 25-75% , indicate that partial sympathectomy denervation is responsible for the longterm increase in bronchomotor tone. In contrast, Cruz et al. [10] observed a mean FEF decrease in small airways and an RV increase 6 months after ETS, but did not observed the changes in FEV1, FVC and TLC 6 months after. The authors focus on the difficulty of explaining the decrease in respiratory function due to sympathetic denervation, but concluded that the bronchial adrenergic modulation is probably more important than was previously thought.
Conversely, when compared with the data of González et al. [6] , we observed a significant difference in respiratory function between the CG and the SG. In the CG, we removed the T2 to T3 ganglia while González et al. disconnected such ganglia on the sympathetic nerve. In theory, more aggressive procedures targeting resection of several ganglia and the intervening chain would cause a major alteration in SNS activity resulting in more dramatic effects on respiratory functions. Any ganglion resection removes the white rami communicants and its axons from cells in the intermedio-lateral cell column of the spinal cord. If these axons are injured or transected, the cell bodies in the spinal cord may die or re-organize. The spinal cord influence over the remaining SNS may be short-circuited by this re-organization; hence, increased sympathetic tone may occur in the remaining sweating body areas. That may explain a case of compensatory hyperhidrosis observed in our CG group, while González et al. [6] did not report any case of compensatory hyperhidrosis. However, how sympathetic denervation causes changes in respiratory function is not well understood.
The parasympathetic nervous system (PNS) is the dominant neuronal pathway in the control of airway smooth muscle tone. Stimulation of cholinergic nerves causes bronchoconstriction, mucus secretion and bronchial vasodilation. The SNS may control tracheobronchial blood vessels, but no innervation of human airway smooth muscle. Despite this, some studies show that sympathetic innervation reaches even the distal area, because amyelinic sympathetic nervous fibres have been detected within bronchiolar smooth muscle and alveolar ducts. That has been confirmed by electronic microscopy, which provided evidence for the presence of adrenergic nerves in the lower respiratory tract [17] . Thus, the increased resistance of the small airway of the CG group may result from a dysfunction of bronchomotor tone caused by sympathetic denervation. A further hypothesis is that the SNS may influence bronchomotore tone indirectly by modulating the influence on PNS. If so, in the PSN-SNS balance, sympathethic denervation increases the physiological cholinergic preponderance; the consequent increased tone of bronchial smooth muscle causes a restriction of small airway as observed in bronchial ashmatic patients. Therefore, sympathectomy allowed the small airway obstructive effects of sympathetic denervation to become more evident. To confirm that, in patients of the CG we observed a significant increase of FEF 25-75% and Raw, similar to those produced by blockade of β2 adrenegic receptors in normal and asthmatic patients [18] .
Secondly, in the CG, we observed cardiac function disturbances as a decrease in HR at rest and at peak. These results from exercise tests resemble the effects of beta-blockers as also observed for respiratory function. It is in line with the studies of Papa et al. [13] and of Noppen et al. [12] who find a lower HR at rest and during effort after T2-T3 sympathectomy.
These findings suggest that the overfunctioning of the sympathetic fibres passing through the T2 and T3 ganglia (which is a hallmark of EH) also affects cardiac autonomic activity. Conversely, in the SG, we did not observe any change in cardiac function before and after the operation despite the sympathetic denervation.
In the resting state, when the stress on the cardiovascular system is minimal, HR is mainly under vagal restraint, whereas during the exercise an increase in HR occurs through simultaneous decrease in vagal activity and increase in sympathetic activity [19] . Probably, the T2-T3 gangliectomy abolish completely the increased reaction of the cardiovascular sympathetic system to stress which is partially reduced by sympathicotomy. This is because the simple chain disconnection between the T2 and T3 ganglia would preserve ganglia and thereby maintain white matter transmission from the spinal cord to the thoracic ganglia as proposed previously. Yet, the significant decrease in the HR at rest in the CG group may be due to the prevalence of PNS effect as a consequence of reducing SNS activity in the PNS/SNS balance. This is because, in such patients, resting HR is (at least partially) also under sympathetic control as confirmed by Tedoriya et al. [20] , and cardiac autonomic activity became vagal predominant after ETS.
In our study population, ETS did not significantly affect ECG and metabolic parameters; after the observed beta-blocking-like effect of thoracoscopic sympathectomy, cardiac output is maintained by a parallel increase in stroke volume through the Frank-Starling mechanism which may explain the increase in oxygen pulse seen in the CG of our patients and already verified by other authors [9] . Thus, all patients were able to perform a maximal exercise test without complications, despite some patients presenting a decrease in the HR.
Despite lower side effects on cardio-respiratory function, in the SG, we had no cases of hyperhidrosis recurrence in agreement with the experience from Mayo Clinic [5] . This may be explained by the fact that the lungs and heart are partially denervated by a section of the sympathetic chain at the T3 level. Conversely, as discussed above, sympathicotomy results in a lower risk of compensatory hyperhidrosis. In theory, the patient's sweating pattern is substantially less altered with sympathicotomy and therefore less susceptible to resultant severe compensatory hyperhidrosis as a complication [5] .
The results of our study are not speculative, and patients should be informed of the possible beta-blocking-like effect on cardiorespiratory function resulting from sympathectomy. O'Connor et al. [21] and Zee [22] reported, respectively, two cases of cardiac arrest after bilateral ETS requiring resuscitation manoeuvres. Lai et al. [23] described a case of symptomatic bradycardia after bilateral ETS which required the permanent pacemaker insertion. Whether asthma is a contraindication for sympathectomy is unclear. Our study did not count patients with respiratory disease as asthma in agreement with the exclusion criteria. In the case study of González et al. [2] , two patients with asthma in stable condition after sympathectomy did not experience respiratory symptoms or the need for rescue bronchodilators, which would suggest a worsening of their background condition. In the light of these considerations, patients should be clearly warned that sympathectomy is not as minor a procedure as usually asserted, and one may seriously reconsider performing bilateral ETS in patients with a positive vagal syndrome and/or unstable asthma which required continuous therapy. If such patients are particularly motivated to undergo ETS because the hyperhidrosis dramatically limits their social activities, the treatment of choice would probably be a more limited denervation as sympathicotomy. As confirmed by our results, it achieves the same clinical benefits but with lower side effects on respiratory and cardiac activity. Thus, sympathicotomy may be extended as the ETS therapy of choice for EPH treatment in competitive athletes.
Study limitations
Our study has some limitations as follows:
(i) Our study was composed of patients affected by EH, and thus having a dysfunction of sympathetic activity. The observed respiratory and clinical effects would probably not be observed in healthy individuals. (ii) The cardio-respiratory effects were observed 6 months after operation. However, a longer postoperative period would be required to determine if they are long-term effects. (iii) The number of patients was too limited, thus our results should be corroborated by larger studies.
CONCLUSION
Our data confirmed that sympathectomy in patients with EPH results in a disturbance of bronchomotor tone and cardiac function. Such changes remain sub-clinical and seem directly correlated with the extension of denervartion. Thus, when a sympathectomy procedure is proposed, changes in respiratory and/or cardiac activity should be elencated as possible side effects. Because of the observed lower side effects on cardio-pulmonary systems, sympathicotomy may be extended as the ETS therapy of choice for EPH treatment in competitive athletes or in patients with respiratory and cardiac disease.
